Markets:

Overview

News

Currencies

International

Treasuries

UiPath, Inc. Class A Common Stock (NY:PATH)

16.39 +1.13 (+7.44%)

Streaming Delayed Price Updated: 3:29 PM EDT, Aug 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about UiPath, Inc. Class A Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

69 70 Next >

UiPath Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

March 12, 2025

From UiPath, Inc.

Via Business Wire

UiPath Stock Rises Ahead Of Q4 Results Due Wednesday: Retail’s Convinced Of Long-term Potential ↗

March 12, 2025

UiPath’s guidance issued in early December calls for revenue of $422 million to $427 million and ARR of $1.669 billion to $1.674 billion.

Via Stocktwits

UiPath (PATH) Reports Earnings Tomorrow: What To Expect

March 11, 2025

Automation software company UiPath (NYSE:PATH) will be reporting results tomorrow afternoon. Here’s what investors should know.

Via StockStory

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip ↗

March 08, 2025

Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.

Via Benzinga

Should Investors Buy UiPath Stock? ↗

March 08, 2025

Via The Motley Fool

Looking Into UiPath's Recent Short Interest ↗

February 11, 2025

Via Benzinga

Deep Dive Into UiPath Stock: Analyst Perspectives (9 Ratings) ↗

January 10, 2025

Via Benzinga

Earnings Scheduled For March 12, 2025 ↗

March 12, 2025

Via Benzinga

UiPath Expands Healthcare Automation with New Global Professional Services Capabilities for Electronic Medical Records Platform

March 03, 2025

From UiPath

Via Business Wire

What's Wrong With UiPath's Stock? ↗

January 08, 2025

Via The Motley Fool

2 Undervalued Growth Stocks Investors Can Buy Right Now in 2025 ↗

February 18, 2025

Via The Motley Fool

Palantir Stock Is Up 585% Since Early 2024. History Is Clear About What Happens Next. ↗

February 15, 2025

Via The Motley Fool

UiPath Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results Conference Call

February 12, 2025

From UiPath, Inc.

Via Business Wire

UiPath to Showcase How Agentic Automation is Transforming the Healthcare Industry at ViVE 2025 Conference

February 12, 2025

From UiPath

Via Business Wire

Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs ↗

February 10, 2025

On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company.

Via Benzinga

Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday ↗

February 08, 2025

Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.

Via Benzinga

uiPath Stock Jumps On Positive In-House Report On Agentic AI Adoption: Retail Optimism Grows ↗

January 28, 2025

UiPath’s RPA tool uses software robots to automate repetitive tasks and it is deployed by small, midsize and enterprise businesses.

Via Stocktwits

Topics Artificial Intelligence

UiPath Report Reveals Agentic AI is Driving Investment to Tackle More Complex Business Workflows

January 27, 2025

From UiPath

Via Business Wire

President Trump Unveils $500 Billion AI Infrastructure: Watch AI, PRSO, BBAI Among The Giants

January 22, 2025

Via AB Newswire

Topics Artificial Intelligence Government

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies ↗

January 22, 2025

Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.

Via Benzinga

Topics Government

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia ↗

January 18, 2025

Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.

Via Benzinga

Topics Artificial Intelligence

10 Information Technology Stocks Whale Activity In Today's Session ↗

January 15, 2025

Via Benzinga

Top 3 High-Risk, High-Reward Plays for Bullish Investors

January 13, 2025

The January effect often leaves investors feeling optimistic to start a new year: these three high-risk, high-reward stock plays may appeal to bulls.

Via MarketBeat

Topics Economy

The Next Stage of the Artificial Intelligence (AI) Revolution Has Arrived -- Say Hello to Digital Labor ↗

January 11, 2025

What happens when AI starts writing its own instructions? Digital labor is evolving faster than you think.

Via The Motley Fool

Topics Artificial Intelligence

UiPath Stock Was Down 50% in 2024, but Could Artificial Intelligence (AI) Agents Turn It Around in 2025? ↗

January 10, 2025

Via The Motley Fool

Topics Artificial Intelligence

2 Agentic Artificial Intelligence (AI) Stocks to Consider Buying ↗

January 08, 2025

Via The Motley Fool

Topics Artificial Intelligence

UiPath to Participate in the 27th Annual Needham Growth Conference

January 07, 2025

From UiPath, Inc.

Via Business Wire

3 Reasons to Sell PATH and 1 Stock to Buy Instead

January 07, 2025

UiPath has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.4% to $14.03 per share while the index has gained 7.3%.

Via StockStory

Topics Stocks

FuboTV, Serve Robotics, SolarEdge Technologies And Other Big Stocks Moving Higher On Monday ↗

January 06, 2025

Via Benzinga

3 No-Brainer Artificial Intelligence (AI) Stocks to Buy for 2025 With $200 Right Now ↗

January 06, 2025

Via The Motley Fool

Topics Artificial Intelligence

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.